Anti-IL-9 (Fig. 5A) but not anti-IL-10 (Fig. 5B) antibodies impaired the PD-1-elevating activity of CLL cell supernatants in healthy CTLs. Here, IL10 is linked to B-cell chronic lymphocytic leukemia.